UnitedHealth Group (NYSE:UNH) had its price target boosted by Argus to $270.00 in a research report sent to investors on Thursday. They currently have a buy rating on the healthcare conglomerate’s stock.

A number of other research firms also recently weighed in on UNH. Deutsche Bank boosted their target price on UnitedHealth Group to $260.00 and gave the stock a buy rating in a research report on Wednesday. Citigroup boosted their target price on UnitedHealth Group from $235.00 to $268.00 and gave the stock a buy rating in a research report on Wednesday. Piper Jaffray Companies restated a buy rating and set a $259.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Royal Bank of Canada boosted their target price on UnitedHealth Group from $269.00 to $280.00 and gave the stock an outperform rating in a research report on Wednesday. Finally, BMO Capital Markets upped their price objective on UnitedHealth Group from $14.50 to $275.00 and gave the company an outperform rating in a report on Wednesday. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of $243.22.

Shares of UnitedHealth Group (NYSE UNH) opened at $243.35 on Thursday. The firm has a market capitalization of $235,822.70, a price-to-earnings ratio of 24.14, a PEG ratio of 1.42 and a beta of 0.66. UnitedHealth Group has a 52-week low of $156.49 and a 52-week high of $244.35. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.11 earnings per share. research analysts forecast that UnitedHealth Group will post 12.52 EPS for the current year.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders sold 33,655 shares of company stock valued at $7,469,083 over the last 90 days. Corporate insiders own 0.89% of the company’s stock.

Institutional investors have recently made changes to their positions in the business. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group in the second quarter worth about $110,000. Bruderman Asset Management LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its holdings in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares in the last quarter. BDO Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth about $121,000. Finally, Acrospire Investment Management LLC boosted its position in shares of UnitedHealth Group by 130.7% during the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after buying an additional 400 shares during the period. Institutional investors own 86.09% of the company’s stock.

WARNING: This report was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://www.watchlistnews.com/unitedhealth-group-unh-given-new-270-00-price-target-at-argus/1816856.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.